廣濟藥業(000952.SZ):大容量注射劑(玻瓶、軟袋)(最終滅菌)獲GMP認證通過
格隆匯1月17日丨廣濟藥業(000952.SZ)公佈,公司近日收到湖北省藥品監督管理局核准簽發的《藥品GMP認證檢查結果通知》,現將相關情況公告如下:
公司於2019年9月10日向湖北省藥品監督管理局申請GMP認證證書核發,於2019年10月29日-2019年11月1日接受檢查,檢查結論為:經審核,本次藥品GMP認證符合《藥品生產質量管理規範(2010年修訂)》要求,現將檢查結果予以告知。
編號:(鄂)藥認字S20190010;認證範圍:大容量注射劑(玻瓶、軟袋)(最終滅菌);受理編號:20190030291;發證機關:湖北省藥品監督管理局。
此次GMP認證通過,標誌着公司可以生產大容量注射劑(玻瓶、軟袋)產品,公司將根據市場需求情況進行生產和銷售,提升公司經營業績水平,推動企業高質量發展。公司始終堅持“質量是企業的生命”的經營理念,不斷提高公司質量管理水平,積極維護消費者權益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.